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EPISODIC PAROXYSMAL HEMICRANIA
WITH SEASONAL VARIATION
Case report and the EPH-cluster
headache continuum hypothesis
Germany Gonçalves Veloso, Alexandre Ottoni Kaup,
Mario F Pietro Peres, Eliova Zukerman
ABSTRACT - Episodic paroxysmal hemicrania (EPH) is a rare disorder characterized by frequent, daily attacks of
short-lived, unilateral headache with accompanying ipsilateral autonomic features. EPH has attack periods
which last weeks to months separated by remission intervals lasting months to years, however, a seasonal
variation has never been reported in EPH. We report a new case of EPH with a clear seasonal pattern: a 32-
year-old woman with a right-sided headache for 17 years. Pain occurred with a seasonal variation, with bouts
lasting one month (usually in the first months of the year) and remission periods lasting around 11 months.
During these periods she had headache from three to five times per day, lasting from 15 to 30 minutes,
without any particular period preference. There were no precipitating or aggravating factors. Tearing and
conjunctival injection accompanied ipsilaterally the pain. Previous treatments provided no pain relief. She
completely responded to indomethacin 75 mg daily. After three years, the pain recurred with longer attack
duration and was just relieved with prednisone. We also propose a new hypothesis: the EPH-cluster headache
continuum.
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Hemicrânia paroxística episódica com variação sazonal: relato de caso e hipótese do continuum HPE-
cefaléia em salvas
RESUMO - A hemicrânia paroxística episódica (HPE) é um tipo raro de cefaléia em que ocorrem breves episódios
de intensa cefaléia hemicrânica, recorrendo várias vezes por dia e acompanhada de sinais autonômicos
ipsilaterais. Estas dores se repetem, em geral, por períodos sintomáticos que duram de semanas a meses,
separados por intervalos assintomáticos de meses a anos; no entanto, uma variação sazonal nunca foi relatada
nesses casos. Descreveremos um caso de HPE com um nítido padrão sazonal. Trata-se de mulher de 32 anos,
que referia dor hemicrânica à direita, mas principalmente periorbitária, em queimação, há 17 anos. A dor
sempre ocorria durante 1 mês e com intervalos assintomáticos de 11 meses. Durante períodos sintomáticos a
dor ocorria de 3 a 5 vezes por dia, com duração de 15 a 30 minutos, sem horário preferencial. Em 30% dos
ataques apresentava lacrimejamento e congestão conjuntival. Não havia fatores desencadeantes ou de piora.
No momento do exame, a paciente queixava-se da dor há 20 dias. O exame neurológico era normal. A
tomografia de crânio, normal. Após a introdução de indometacina a paciente referiu desaparecimento da dor
em 48 horas. Após três anos, a dor recorreu com duração mais longa e foi aliviada apenas com prednisona.
Também propomos uma hipótese: o continuum EPH-cefaléia em salvas.
PALAVRAS-CHAVE: hemicrania paroxística episódica, disfunção cronobiológica, continuum HPE-cefaléia em salvas.
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Episodic paroxysmal hemicrania (EPH) is a rare
disorder characterized by frequent, daily attacks
of short-lived, unilateral headache with accom-
panying ipsilateral autonomic features. These hea-
daches occur, in general, for many years until they
are diagnosed and treated. EPH distinguishes from
chronic paroxysmal hemicrania (CPH) by its tem-
poral profile: EPH has attack periods, which last
weeks to months separated, by remission inter-
vals lasting months to years whereas CPH occurs
without remission periods.
We report a new case of EPH with a clear seaso-
nal pattern and propose a new hypothesis: the EPH-
cluster headache continuum.
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CASE
A 32-year-old woman complained of a strictly right-
sided headache, mainly periorbital, burning type, for 17
years. Pain occurred with a seasonal variation, with bouts
lasting one month (usually in the first months of the year)
and remission periods lasting around 11 months. During
these periods she had headache from three to five times
per day, lasting from 15 to 30 minutes, without any par-
ticular period preference. There were no precipitating or
aggravating factors. In one third of the attacks she had
tearing and conjunctival injection ipsilaterally to the pain.
Previous treatments with ergotamine, diazepam, fluna-
rizine and carbamazepine provided no relief. Her neuro-
logical examination and CT scan of the brain were nor-
mal. After she started Indomethacin 75 mg daily she had
complete remission in 48 hours. After three years, the pain
recurred. At this time, it lasted around 30 minutes, occur-
ring three times a day. No relief was experienced with in-
domethacin but treatment with prednisone resulted in an
improvement.
DISCUSSION
EPH is a rare primary headache, described first
by Kudrow, Esperanza and Vijayan in 19871, who
also have named it. It is characterized by unilateral
pain attacks in the orbital, supra-orbital or temporal
region, between 1 to 30 minutes duration and se-
vere intensity. It is accompanied by the ipsilateral
autonomic symptoms such as conjunctival injection,
tearing, nasal congestion, rhinorrhea, ptosis and
palpebral edema. The pain occurs in a frequency of
over 3 times a day (in general, 3 to 30 episodes).
These periods last from some weeks to months and
between them there are asymptomatic intervals last-
ing from months to years, in a similar pattern to
episodic cluster headache2. The pain is described as
throbbing or stabbing. It occurs in both sex, with a
slight female preponderance (1,3:1), different from
the female predominance seen in CPH cases (3:1)3.
The age of onset varies from 12 to 51 years4. There
were 23 cases reported of EPH at the time of writing
(Table 1).
Our patient had a clear seasonal variation; her
headache bouts lasted for one month, and usually
occurred in January, February or March, consistently
for 17 years. This is the first EPH case with a clear
seasonal variation.
Table 1. Summary of EPH reported cases.
Case Reference Sex Age Age at Daily attack Duration of Duration of Duration of
onset frequency individual headache remission
attacks (min) phase (months) phase (months)
1 (1) F 38 12 8-20 10-15 1 4-6
2 F 84 51 3-6 15-20 3-4 3-6
3 F 30 21 14-15 5-15 2-4 24
4 M 49 14 6-8 20-30 1 3-5
5 M 45 27 4-9 1-20 2 11
6 M 56 37 30 15 3-4 2-3
7 (17) M 52 18 20 10-30 1-2 1,5-5
8 (18) M 29 26 30 20 1-3 1-3
9 (19) M 59 42 10 5-10 1 1-4
10 (20) F 40 16 20 10-20 3-3,5 3-36
11 (2) F 54 48 10-20 2-3 1 3-4
12 F 28 25 15-20 15-30 1 3
13 (15) F 48 44 5-10 15 0,75 0,75
14 F 23 19 5-10 3 0,25 0,75
15 F 35 33 5-15 10 0,75 5,5
16 M 37 25 3-6 15 0,50 3
17 F 25 23 2-6 5 0,25 0,50
18 M 42 20 15-20 15 0,50 2
19 (6) M 63 34 4-12 10-15 2 4
20 F 58 54 7-20 10 0,75 2
21 M 39 10 5 15 4,5 0,75
22 F 35 27 3-5 1-2 6 10-12
23 Veloso et al. F 32 15 3-5 15-30 1 11
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Table 2. Criteria proposed to paroxysmal hemicrania.
Chronic Paroxysmal Hemicrania
Diagnostic criteria:
A. At least 30 attacks fulfilling B-E
B. Attacks of severe unilateral orbital, supraorbital and/or temporal pain always on the same side lasting 2-45 min
C. Attack frequency above 5 a day for more than half the time (periods with lower frequency may occur)
D. Pain is associated with at least one of the following sign/symptoms on the pain side:
1. Conjunctival injection
2. Lacrimation
3. Nasal congestion
4. Rhinorrhea
5. Ptosis
6. Eyelid oedema
E. At least one of the following:
1. There is no suggestion of one the disorders listed in groups 5-11
2. Such a disorder is suggested but excluded by appropriate investigations
3. Such a disorder is present, but the first headache attacks do not occur in close temporal relation to the disorder.
Note: most cases respond rapidly and absolutely to indomethacin (usually in doses of 150mg/day or less)
Episodic Paroxysmal Hemicrania
Diagnostic criteria:
A. At least 30 attacks fulfilling B-F
B. Attacks of severe unilateral orbital or temporal, or both, that is always unilateral and last 1-30 min
C. Attack frequency of 3 or more a day
D. Clear intervals between bouts of attacks that may last from months to years
E. Pain is associated with at least one of the following sign or symptoms on the painful side
1. Conjunctival injection
2. Lacrimation
3. Nasal congestion
4. Rhinorrhea
5. Ptosis
6. Eyelid oedema
F. At least one of the following:
1. There is no suggestion of one the disorders listed in groups 5-11
2. Such a disorder is suggested but excluded by appropriate investigations
3. Such a disorder is present, but the first headache attacks do not occur in close temporal relation to the disorder.
Note: most cases respond rapidly and absolutely to indomethacin (usually 150mg/day or less)
Sjaastad suggested EPH could be a remittent form
of CPH, but not a separate clinical entity5. It is likely
that EPH and CPH are ends of a spectrum just as
episodic and chronic cluster headache4. It would ran-
ge from a form with alternating active and inactive
periods (EPH), to another without asymptomatic
periods (CPH) A continuous form evolving from the
remitting course could also occur6.
The International Headache Society (IHS) classifi-
cation does not include EPH, but CPH is mentioned
as a variant of cluster headache. Goadsby and Lipton4
proposed diagnostic criteria (Table 2) for chronic and
episodic paroxysmal hemicrania using the structure
of the cluster headache criteria as a model4. Our
patient met those criteria.
EPH could be considered as one of the trigemino
autonomic cephalgias, therefore it could share the
same mechanisms4. In this particular case, the sea-
sonal variation presented by the patient suggests
the role of hypothalamus in the pathophysiology of
EPH, particularly the biological clock (suprachiasmatic
nuclei) and the involvement of melatonin secretion.
Melatonin is the most sensitive surrogate marker
of circadian function in humans, and its rhythmic
secretion is under the control of the hypothalamus7.
Melatonin secretion is marked influenced by seasonal
changes in the light-dark cycle and plays a role in
the effects of season on animal physiology and be-
havior8. Decreased melatonin levels have been re-
ported in cluster headache patients (9,10) and me-
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latonin has been used for the prophylactic treatment
of cluster headache11. Melatonin has been shown to
play a role in cluster headache circannual variation12
and it may play a role in EPH seasonal variation as
well. Indomethacin and melatonin have a similar
structural formula13, so indomethacin responsiveness
could be related to melatonin’s biological activity.
The circannual variation of the attacks in EPH has
to be studied prospectively in order to support a
possible chronobiological dysfunction in this type
of headache. Further functional neuroimaging stud-
ies could also support a hypothalamic involvement
in EPH. Indomethacin is the first choice treatment
for cases of EPH. The initial dosage recommended is
75 mg per day. This dosage should be kept for 2
days. If there is no response, the dose has to be in-
creased up to 250 mg a day. The medication brings
often a fast response, occurring generally in the first
48 hours. The absence of response after 3 days of
this treatment weakens the diagnosis of EPH. In a
study by Pareja and Sjaastad, indomethacin produced
a total relief of pain in the first 24 hours in almost all
patients14. In general, the treatment is kept for a time
that is slightly over the symptomatic periods of pa-
tient, and then it starts a gradual withdrawal6.
Other drugs such as aspirin, naproxen, ibuprofen,
paracetamol, mefenamic acid and corticosteroids
were tested without success2. There are reports of
improvement with calcium channel blockers, mainly
with flunarizine and nicardipine15. A CPH case respon-
sive to celecoxib was recently reported16. This new
nonsteroidal anti-inflammatory drug could be an
alternative treatment, although it has never been
proved to be effective in EPH. The IHS considers the
response to indomethacin as a criterion for the di-
agnosis of CPH but there is no mention to EPH. De-
finitive classification and diagnostic criteria is still
lacking for EPH.
The main differential diagnosis of EPH is episodic
cluster headache, although rare intracranial lesions
that can simulate EPH have to be excluded6. Cluster
headache differs from EPH because the shorter du-
ration, higher daily frequency and an absolute re-
sponse to indomethacin in EPH (although, the latter
is not considered as a good criterion for some au-
thors4. Besides that, cluster headache has a remark-
able predominance in men, something that does not
occur in EPH. Both present the same temporal pro-
file with symptomatic periods of multiple attacks of
strictly unilateral headaches of short duration with
ipsilateral autonomic symptoms, separated by as-
ymptomatic periods. In general, as the attack fre-
quency increases above 4 to 5 painful episodes per
day and the duration of these decreases below 30
minutes, the diagnosis of EPH becomes more likely6.
There is an overlap between EPH and cluster head-
ache diagnostic criteria: the range from 15 to 30
minutes in the headache duration and the range
from 3 to 8 attacks a day in headache frequency.
Our patient latest symptomatic period had pains with
duration around 30 minutes and frequency of 3 at-
tacks a day, which is into these ranges. And as EPH
and episodic cluster headache have many similar
features, we hypothesized the existence of an EPH-
cluster headache continuum. Further clinical studies
and larger case series are necessary to support this
hypothesis.
REFERENCES
1. Kudrow L, Esperanza P, Vijayan N. Episodic paroxysmal hemicrania?
Cephalalgia 1987;7:197-201.
2. Newman LC, Gordon ML, Lipton RB, Kanner R, Solomon S. Episodic
paroxysmal hemicrania: two new cases and a literature review. Neu-
rology 1992;42:964-966.
3. Antonaci F, Sjaastad O. Chronic paroxysmal hemicrania (CPH): a re-
view of the clinical manifestations. Headache 1989;29:648-656.
4. Goadsby PJ, Lipton RB. A review of paroxysmal hemicranias, SUNCT
syndrome and other short-lasting headaches with autonomic feature,
including new cases. Brain 1997;120:193-209.
5.  Sjaastad O. Paroxysmal hemicrania. Neurology 1993;43:1445-1447.
6. Newman LC, Lipton RB, Solomon S. Episodic paroxysmal hemicrania:
3 new cases and a review of the literature. Headache 1993;33:195-197.
7. Brzezinski A. Melatonin in Humans. N Eng J Med 1997;336:186-195.
8. Wehr TA. Melatonin and seasonal rhythms. J Biol Rhythms 1997;12:518-
527.
9. Leone M, Lucini V, D’Amico D, et al. Twenty-four-hour melatonin and
cortisol plasma levels in relation to timing of cluster headache. Ceph-
alalgia 1995;15:224-229.
10. Waldenlind E, Ekbom K, Wetterberg L, et al. Lowered circannual uri-
nary melatonin concentrations in episodic cluster headache. Cephala-
lgia 1994;14:199-204.
11. Leone M, D’Amico D, Moschiano F, Fraschini F, Bussone G. Melatonin
versus placebo in the prophylaxis of cluster headache: a double-blind
pilot study with parallel groups. Cephalalgia 1996;16:494-496.
12. Leone M, Lucini V, D’Amico D, et al. Abnormal 24-hour urinary excre-
tory pattern of 6-sulphatoxymelatonin in both phases of cluster head-
ache. Cephalalgia 1998;18:664-667.
13. Kelly RW, Amato F, Seamark RF. N-acetyl-5-methoxy kynurenamine,
a brain metabolite of melatonin, is a potent inhibitor of prostaglandin
biosynthesis. Biochem Biophys Res Commun 1984;121:372-379.
14. Pareja JA, Sjaastad O. Chronic paroxysmal hemicrania and hemicrania
continua: interval between indomethacin administration and response.
Headache 1996;36:20-23.
15. Coria F, Claveria LE, Jimenez-Jimenez FJ, De Seijas EV. Episodic par-
oxysmal hemicrania responsive to calcium channel blockers. J Neurol
Neurosurg Psychiatry 1992;55:166.
16. Mathew NT, Kailasam J, Fischer. A responsiveness to celecoxib in
chronic paroxysmal hemicrania. Neurology 2000:55:316.
17. Geaney DP. Indomethacin-responsive episodic cluster headache. J
Neurol Neurosurg Psychiatry 1983;46:860-861.
18. Bogucki A, Niewodniczy A. Case report: chronic cluster headache with
unusual high frequency of attacks. Headache 1984;24:150-151.
19. Spierings ELH. The chronic paroxysmal hemicrania concept expanded.
Headache 1988;28:597-598.
20. Blau JN, Engel H. Episodic paroxysmal hemicrania: a further case and re-
view of the literature. J Neurol Neurosurg Psychiatry 1990;53:343-344.
